A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

10.1016/j.canlet.2016.07.023

Saved in:

Bibliographic Details
Main Authors:	Ong, Pei-Shi, Wang, Lingzhi, Chia, Deborah Miao-Hui, Seah, Jolyn Yu-Xin, Kong, Li-Ren, Thuya, Win-Lwin, Chinnathambi, Arunachalam, Lau, Jie-Ying Amelia, Wong, Andrea Li-Ann, Yong, Wei-Peng, Yang, Daiwen, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon-Cher
Other Authors:	BIOLOGY (NU)
Format:	Article
Language:	English
Published:	ELSEVIER IRELAND LTD 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Belinostat (R) Seliciclib (R) Non-small cell lung cancer Caspase-8 activation Truncated BID HISTONE DEACETYLASE INHIBITORS DEPENDENT KINASE INHIBITOR DEATH P53 FLAVOPIRIDOL ENHANCEMENT CARBOPLATIN ROSCOVITINE EXPRESSION PACLITAXEL
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175510
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-175510
record_format	dspace
spelling	sg-nus-scholar.10635-1755102024-04-18T03:03:47Z A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation Ong, Pei-Shi Wang, Lingzhi Chia, Deborah Miao-Hui Seah, Jolyn Yu-Xin Kong, Li-Ren Thuya, Win-Lwin Chinnathambi, Arunachalam Lau, Jie-Ying Amelia Wong, Andrea Li-Ann Yong, Wei-Peng Yang, Daiwen Ho, Paul Chi-Lui Sethi, Gautam Goh, Boon-Cher BIOLOGY (NU) CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE PHARMACOLOGY PHARMACY Science & Technology Life Sciences & Biomedicine Oncology Belinostat (R) Seliciclib (R) Non-small cell lung cancer Caspase-8 activation Truncated BID HISTONE DEACETYLASE INHIBITORS DEPENDENT KINASE INHIBITOR DEATH P53 FLAVOPIRIDOL ENHANCEMENT CARBOPLATIN ROSCOVITINE EXPRESSION PACLITAXEL 10.1016/j.canlet.2016.07.023 CANCER LETTERS 381 1 49-57 NETHERLANDS 2020-09-10T01:56:48Z 2020-09-10T01:56:48Z 2016-10-10 2020-09-09T22:31:23Z Article Ong, Pei-Shi, Wang, Lingzhi, Chia, Deborah Miao-Hui, Seah, Jolyn Yu-Xin, Kong, Li-Ren, Thuya, Win-Lwin, Chinnathambi, Arunachalam, Lau, Jie-Ying Amelia, Wong, Andrea Li-Ann, Yong, Wei-Peng, Yang, Daiwen, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon-Cher (2016-10-10). A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation. CANCER LETTERS 381 (1) : 49-57. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2016.07.023 03043835 18727980 https://scholarbank.nus.edu.sg/handle/10635/175510 en ELSEVIER IRELAND LTD Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology Belinostat (R) Seliciclib (R) Non-small cell lung cancer Caspase-8 activation Truncated BID HISTONE DEACETYLASE INHIBITORS DEPENDENT KINASE INHIBITOR DEATH P53 FLAVOPIRIDOL ENHANCEMENT CARBOPLATIN ROSCOVITINE EXPRESSION PACLITAXEL
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology Belinostat (R) Seliciclib (R) Non-small cell lung cancer Caspase-8 activation Truncated BID HISTONE DEACETYLASE INHIBITORS DEPENDENT KINASE INHIBITOR DEATH P53 FLAVOPIRIDOL ENHANCEMENT CARBOPLATIN ROSCOVITINE EXPRESSION PACLITAXEL Ong, Pei-Shi Wang, Lingzhi Chia, Deborah Miao-Hui Seah, Jolyn Yu-Xin Kong, Li-Ren Thuya, Win-Lwin Chinnathambi, Arunachalam Lau, Jie-Ying Amelia Wong, Andrea Li-Ann Yong, Wei-Peng Yang, Daiwen Ho, Paul Chi-Lui Sethi, Gautam Goh, Boon-Cher A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
description	10.1016/j.canlet.2016.07.023
author2	BIOLOGY (NU)
author_facet	BIOLOGY (NU) Ong, Pei-Shi Wang, Lingzhi Chia, Deborah Miao-Hui Seah, Jolyn Yu-Xin Kong, Li-Ren Thuya, Win-Lwin Chinnathambi, Arunachalam Lau, Jie-Ying Amelia Wong, Andrea Li-Ann Yong, Wei-Peng Yang, Daiwen Ho, Paul Chi-Lui Sethi, Gautam Goh, Boon-Cher
format	Article
author	Ong, Pei-Shi Wang, Lingzhi Chia, Deborah Miao-Hui Seah, Jolyn Yu-Xin Kong, Li-Ren Thuya, Win-Lwin Chinnathambi, Arunachalam Lau, Jie-Ying Amelia Wong, Andrea Li-Ann Yong, Wei-Peng Yang, Daiwen Ho, Paul Chi-Lui Sethi, Gautam Goh, Boon-Cher
author_sort	Ong, Pei-Shi
title	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
title_short	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
title_full	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
title_fullStr	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
title_full_unstemmed	A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation
title_sort	novel combinatorial strategy using seliciclib (r) and belinostat (r) for eradication of non-small cell lung cancer via apoptosis induction and bid activation
publisher	ELSEVIER IRELAND LTD
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/175510
_version_	1800914367267471360

A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation

Similar Items